Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.74
-0.21 (-0.92%)
Nov 10, 2026, 4:00 PM EST - Market closed

Fresenius Medical Care AG Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Fresenius Medical Care AG stock has a consensus rating of "Hold" and an average price target of $22.45. The average 1-year stock price forecast is 1.28% lower than the current stock price, while the lowest is $16.19 (-28.80%) and the highest is $34.89 (+53.43%).

Price Target: $22.45 (-1.28%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$16.19$22.45$22.68$34.89
Change-28.80%-1.28%-0.26%+53.43%

Analyst Ratings

The average analyst rating for Fresenius Medical Care AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy211010
Buy011101
Hold222333
Sell122222
Strong Sell111111
Total677777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Sell
Maintains
n/a
SellMaintainsn/an/aNov 5, 2026
Truist Financial
Truist Financial
Hold
Maintains
$25 → $24
HoldMaintains$25 → $24+5.54%Oct 12, 2026
Bernstein
Bernstein
Hold
Maintains
$26 → $26
HoldMaintains$26 → $26+13.46%Aug 6, 2026
Exane BNP Paribas
Exane BNP Paribas
Sell
Downgrades
$20
SellDowngrades$20-12.49%Jul 28, 2026

Financial Forecast

Revenue This Year
19.35B
from 19.63B
Decreased by -1.40%
Revenue Next Year
19.96B
from 19.35B
Increased by 3.16%
EPS This Year
4.05
from 4.28
Decreased by -5.40%
EPS Next Year
3.86
from 4.05
Decreased by -4.69%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
17.62B19.40B19.45B19.34B19.63B19.35B
Revenue Growth
-1.35%10.10%0.29%-0.61%1.51%-1.40%
Gross Profit
4.77B4.89B4.93B4.76B5.03B4.89B
Gross Margin
27.09%25.23%25.32%24.60%25.62%25.29%
Operating Income
1.90B1.54B1.52B1.54B1.87B1.83B
Net Income
969.31M673.41M499.00M537.91M978.37M711.02M
EPS
----4.284.05
EPS Growth
----37.62%-5.40%
Forward PE
-----5.03
Dividend / Share
1.351.121.191.441.491.44
Dividend Growth
0.75%-17.04%6.25%21.01%3.47%-3.35%
Free Cash Flow
----1.78B1.46B
No. Analysts
-----17
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High20.2B
Avg19.4B
Low17.3B

Revenue Growth

Revenue Growth202620272028
High
2.7%
Avg
-1.4%
Low
-12.0%

EPS Forecast

EPS202620272028
High4.29
Avg4.05
Low3.82

EPS Growth

EPS Growth202620272028
High
0.2%
Avg
-5.4%
Low
-10.7%